The Division of Gynecologic Oncology at The Cancer Center at Hackensack University Medical Center provides comprehensive diagnostic, treatment, management, and support services for women with gynecologic malignancies, including cancer of the ovaries, uterus, cervix, vagina, vulva, and endometrium.

            As a full-time gynecologic oncologist at The Cancer Center and chief of the division, Dr. Daniel H. Smith heads the gynecologic oncology team. He is joined in the division by other physicians with expertise in gynecologic cancers. Each patient’s care is overseen by Dr. Smith and carried out by the entire gynecologic oncology team. The team brings together experts in gynecologic surgery, medical oncology, radiation oncology, radiology, genetics, and nursing. This specialized approach to treating gynecologic cancers provides patients with the exact type of services they need to battle their specific disease and its physical, emotional, and social side effects.

            Dr. Smith received his medical degree from Harvard Medical School in 1972. He completed a residency in general surgery at Massachusetts General Hospital and a residency in obstetrics/gynecology at Los Angeles County/U.S.C. Medical Center. He completed his fellowship in gynecologic oncology at Memorial Sloan-Kettering Cancer Center, in New York City. After graduation he was on the faculty of Cornell University Medical College and the staffs of Memorial Sloan-Kettering Cancer Center and New York Hospital until he joined the faculty of the Columbia University College of Physicians and Surgeons in 1987. Prior to coming to Hackensack University Medical Center, he was director of gynecologic oncology at Columbia-Presbyterian Medical Center, in New York City, for 15 years.

            As the only physician in the United States to be board-certified in gynecologic oncology, obstetrics/gynecology, and general surgery, Dr. Smith provides a level of medical expertise and continuity of care not found elsewhere. He is qualified to treat surgically not only the primary site of a gynecologic cancer but areas that may be affected by any spread of the cancer, such as the colon, bladder, or vascular system.

            The Division of Gynecologic Oncology is currently starting up a new initiative called the Maureen Fund. The Maureen Fund is a program to identify women at high risk for breast and ovarian cancers and then offer them mammography, ultrasound studies, and blood testing in an effort to improve early detection of these cancers, standardize the treatment, and offer new treatments through research.

            Central to the Maureen Fund’s outreach program is a tumor bank that will correlate genetic and protein thumbprints of patients with their treatments and outcomes. By studying the tumors and patients’ genetic thumbprints, researchers hope to predict who may be at risk for developing breast and ovarian cancers.

Learn More About:
Cervical Cancer
Endometrial Cancer
Ovarian Cancer
Uterine Cancer
Vaginal Cancer
Vulvar Cancer